[go: up one dir, main page]

CN116369521A - A composition capable of promoting intestinal health - Google Patents

A composition capable of promoting intestinal health Download PDF

Info

Publication number
CN116369521A
CN116369521A CN202310231897.8A CN202310231897A CN116369521A CN 116369521 A CN116369521 A CN 116369521A CN 202310231897 A CN202310231897 A CN 202310231897A CN 116369521 A CN116369521 A CN 116369521A
Authority
CN
China
Prior art keywords
sesamin
attapulgite
essential oil
ginger essential
powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202310231897.8A
Other languages
Chinese (zh)
Inventor
雷红
刘金金
农家慧
邓瑜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing University of Finance and Economics
Original Assignee
Nanjing University of Finance and Economics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing University of Finance and Economics filed Critical Nanjing University of Finance and Economics
Publication of CN116369521A publication Critical patent/CN116369521A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a composition with an effect of promoting intestinal health, and belongs to the field of biological medicines. The composition is composed of sesamin powder, ginger essential oil and attapulgite powder, has the functions of improving intestinal dysfunction by the sesamin and ginger essential oil, protecting and repairing intestinal mucosa by the attapulgite, and has the functions of synergism and promotion of intestinal health. Pharmacological tests show that the sesamin powder, ginger essential oil and attapulgite powder composition has the functions of regulating intestinal functions, protecting intestinal mucosa, resisting bacteria and inflammation and promoting intestinal health; the combination of sesamin, ginger essential oil and attapulgite is obviously superior to single use or the combination of the sesamin, ginger essential oil and attapulgite, and has synergistic effect. Toxicological tests have shown that the compositions of the invention are safe to use.

Description

一种具有促进肠道健康作用的组合物A composition capable of promoting intestinal health

技术领域technical field

本发明属于生物医药领域,具体涉及一种具有促进肠道健康作用的组合物。The invention belongs to the field of biomedicine, and in particular relates to a composition capable of promoting intestinal health.

背景技术Background technique

肠道功能直接影响人对食物中营养成分的消化吸收,并且对维持人体其它器官的正常功能非常重要。腹泻、胃肠道功能紊乱、慢性炎症、免疫功能障碍等导致的肠道功能紊乱,都会给患者带来痛苦,损害肠道健康和人体健康。目前防治腹泻等肠道功能紊乱的药物多为止泻药、抗菌抗炎药物,存在副作用大且易产生耐药性等问题。现有技术中,缺乏来源于天然、效果显著、无明显不良反应的改善肠道功能、促进肠道健康的新型口服制剂,以减轻患者的痛苦。Intestinal function directly affects people's digestion and absorption of nutrients in food, and is very important for maintaining the normal functions of other organs of the human body. Intestinal dysfunction caused by diarrhea, gastrointestinal dysfunction, chronic inflammation, immune dysfunction, etc. will bring suffering to patients and damage intestinal health and human health. At present, the drugs used to prevent and treat intestinal disorders such as diarrhea are mostly antidiarrheals, antibacterial and anti-inflammatory drugs, which have problems such as large side effects and easy drug resistance. In the prior art, there is a lack of new oral preparations that are derived from natural sources, have significant effects, and have no obvious adverse reactions to improve intestinal function and promote intestinal health, so as to alleviate the pain of patients.

芝麻素是芝麻籽中的主要功能成分,属于木脂素类;芝麻素具有抗氧化、降低血脂(血清胆固醇、甘油三酯),保护肝肾功能等多种生理活性功能,可应用于医药和保健功能食品领域。Sesamin is the main functional component in sesame seeds, which belongs to lignans; sesamin has various physiologically active functions such as anti-oxidation, lowering blood lipids (serum cholesterol, triglycerides), protecting liver and kidney functions, and can be used in medicine and Health functional food field.

生姜是传统的药食同源的保健品资源,具有健胃暖胃、祛寒祛湿、舒筋活血、抗炎抗菌等多种功能。姜精油是从姜根茎中提取的挥发性物质,呈棕色透明油状液体,具有活血化瘀、抗菌抗炎等药理作用;姜精油含有多种功效物质,如姜酚、姜醇、姜酮、姜烯等,在食品、保健食品、化妆品、药品领域应用广泛。Ginger is a traditional health food resource with the same source of medicine and food. It has multiple functions such as invigorating the stomach and warming the stomach, dispelling cold and dampness, relaxing tendons and activating blood circulation, anti-inflammatory and antibacterial. Ginger essential oil is a volatile substance extracted from the rhizome of ginger. It is a brown transparent oily liquid. It has pharmacological effects such as promoting blood circulation and removing blood stasis, antibacterial and anti-inflammatory. It is widely used in food, health food, cosmetics and pharmaceutical fields.

凹凸棒是一种含水镁铝硅酸盐的层链状结构的粘土矿物,具有独特的微观结构及荷电性质,具有多种优良性能,如吸附性、胶体性等,广泛被应用于医药、化工、农业和环保领域。Attapulgite is a clay mineral with a layered chain structure of hydrous magnesium aluminum silicate. It has a unique microstructure and charging properties, and has a variety of excellent properties, such as adsorption and colloidal properties. It is widely used in medicine, Chemical industry, agriculture and environmental protection fields.

现有技术中,未见芝麻素、姜精油与凹凸棒三者组合配伍用于改善肠道功能紊乱、促进肠道健康的用途的报道。In the prior art, there is no report on the combination of sesamin, ginger essential oil and attapulgite for improving intestinal dysfunction and promoting intestinal health.

发明内容Contents of the invention

本发明的目的是提供一种具有促进肠道健康作用的组合物,为芝麻素粉末、姜精油与凹凸棒粉末组成的组合物,既有芝麻素、姜精油改善肠道功能紊乱的功能,又有凹凸棒保护和修复肠道黏膜功能,三者具有协同增效促进肠道健康的作用。The purpose of the present invention is to provide a composition with the effect of promoting intestinal health, which is a composition composed of sesamin powder, ginger essential oil and attapulgite powder, which not only has the functions of sesamin and ginger essential oil to improve intestinal dysfunction, but also The attapulgite protects and repairs the function of the intestinal mucosa, and the three have a synergistic effect on promoting intestinal health.

所述芝麻素、姜精油、凹凸棒粉末的质量比为0.1-2:0.1-2:10。The mass ratio of the sesamin, ginger essential oil and attapulgite powder is 0.1-2:0.1-2:10.

所述芝麻素由芝麻粕中提取,其中芝麻素含量大于50%;所述姜精油由生姜中提取,其中姜酚含量大于20%;所述凹凸棒粉末,选择凹凸棒晶体含量大于50%、碳酸盐含量小于10%的凹凸棒粘土矿石类型,将凹凸棒粘土矿石研磨至100-320目。该组合物可以按公知的工艺加工成口服制剂,如颗粒剂、片剂、胶囊、软胶囊等。The sesamin is extracted from sesame meal, wherein the sesamin content is greater than 50%; the ginger essential oil is extracted from ginger, wherein the gingerol content is greater than 20%; the attapulgite powder is selected to have an attapulgite crystal content greater than 50%, Attapulgite clay ore type with carbonate content less than 10%, grind the attapulgite clay ore to 100-320 mesh. The composition can be processed into oral preparations according to known techniques, such as granules, tablets, capsules, soft capsules and the like.

药理试验表明,本发明的芝麻素粉末、姜精油、凹凸棒粉末组合物具有调理肠道功能、保护肠黏膜、抗菌抗炎、促进肠道健康的作用;芝麻素+姜精油+凹凸棒三者组合明显优于单用或两者组合,具有协同作用。毒理试验表明,本发明的组合物应用安全。Pharmacological tests show that the sesamin powder, ginger essential oil, and attapulgite powder composition of the present invention have the effects of regulating intestinal function, protecting intestinal mucosa, antibacterial and anti-inflammatory, and promoting intestinal health; the combination of sesamin + ginger essential oil + attapulgite Combination is obviously better than single use or combination of both, and has synergistic effect. Toxicological tests show that the composition of the invention is safe to use.

具体实施方式Detailed ways

下面结合实施例对本发明作进一步地描述。The present invention will be further described below in conjunction with embodiment.

实施例1Example 1

一种具有促进肠道健康作用的组合物由从芝麻粕中提取的芝麻素粉末、从生姜中提取的姜精油、和凹凸棒粉末混合均匀组成,三者的配比为1:1:10。A composition capable of promoting intestinal health is composed of sesamin powder extracted from sesame meal, ginger essential oil extracted from ginger, and attapulgite powder, and the ratio of the three is 1:1:10.

(1)芝麻素提取物的制备(1) Preparation of Sesamin Extract

芝麻素提取物的制备方法:将芝麻粕研磨成粉末,加入芝麻粕粉末体积2倍的正己烷,搅拌3h进行脱脂,过滤后再采用相同方法进行第2次脱脂,过滤后后风干,得到脱脂芝麻粕。按照按照每克脱脂芝麻粕中加入8.5ml的93%乙醇水溶液的比例,在脱脂芝麻粕中加入93%乙醇水溶液,在55℃水浴中搅拌,提取2.5h,过滤,分离提取液和脱脂芝麻粕,然后采用相同方法对脱脂芝麻粕重复提取一次。合并两次的提取液,过滤,将滤液在旋转蒸发仪上蒸出部分乙醇,减压浓缩,60℃真空干燥,得芝麻素提取物,其中芝麻素的含量为698.07mg/g。本品性状为:浅褐色粉末,无臭,无味,有吸湿性,溶于醇,不溶于水。The preparation method of sesamin extract: grind the sesame meal into powder, add n-hexane twice the volume of the sesame meal powder, stir for 3 hours to degrease, and then use the same method for the second degreasing, after filtering, air-dry to obtain degreasing Sesame meal. According to the ratio of adding 8.5ml of 93% ethanol aqueous solution per gram of defatted sesame meal, add 93% ethanol aqueous solution to the defatted sesame meal, stir in a water bath at 55°C, extract for 2.5h, filter, and separate the extract and defatted sesame meal , and then use the same method to repeat the extraction of defatted sesame meal once. Combine the two extracts, filter, evaporate part of the ethanol from the filtrate on a rotary evaporator, concentrate under reduced pressure, and vacuum dry at 60°C to obtain a sesamin extract, wherein the content of sesamin is 698.07mg/g. The properties of this product are: light brown powder, odorless, tasteless, hygroscopic, soluble in alcohol, insoluble in water.

其中芝麻素含量测定方法如下:采用HPLC法。芝麻素标准品溶液在20-100μg/ml之间,相应峰面积与芝麻素质量浓度有显著的线性关系,制作标准曲线。用色谱纯无水乙醇将芝麻素提取物溶解,过滤。柱温:室温;流动相:甲醇-水(8:2,v/v);流速0.8ml/min;进样量:20μl;检测波长290nm;分析时间:15min。根据标样的保留时间进行定性,用外标法计算芝麻素的含量。Wherein the determination method of sesamin content is as follows: adopt HPLC method. The sesamin standard solution is between 20-100 μg/ml, and the corresponding peak area has a significant linear relationship with the sesamin mass concentration, and a standard curve is made. Dissolve the sesamin extract with chromatographically pure absolute ethanol, and filter. Column temperature: room temperature; mobile phase: methanol-water (8:2, v/v); flow rate: 0.8ml/min; injection volume: 20μl; detection wavelength: 290nm; analysis time: 15min. According to the retention time of the standard sample, the content of sesamin was calculated by the external standard method.

(2)姜精油的制备(2) Preparation of Ginger Essential Oil

姜精油的制备方法如下:生姜去皮洗净切片,干燥后粉碎,得到生姜粉。在生姜粉中加入70%乙醇溶液回流提取2次,第一次提取中加入生姜粉体积10倍的70%乙醇溶液,提取90min;第二次提取中加入生姜粉体积8倍的70%乙醇溶液,提取60min,合并乙醇提取液,过滤,滤液减压浓缩蒸尽乙醇,得姜精油。本品性状为:浅黄色油状物,有辛辣味,溶于醇,不溶于水。姜精油中姜酚含量为246.25mg/g。The preparation method of ginger essential oil is as follows: ginger is peeled, washed and sliced, dried and pulverized to obtain ginger powder. Add 70% ethanol solution to the ginger powder for reflux extraction twice, add 70% ethanol solution with 10 times the volume of ginger powder in the first extraction, and extract for 90 minutes; add 70% ethanol solution with 8 times the volume of ginger powder in the second extraction , extracted for 60 min, combined ethanol extracts, filtered, and the filtrate was concentrated under reduced pressure and evaporated to exhaust ethanol to obtain ginger essential oil. The properties of this product are: light yellow oily substance with pungent taste, soluble in alcohol, insoluble in water. The content of gingerol in ginger essential oil is 246.25mg/g.

其中,姜酚含量测定方法如下:采用HPLC法;用色谱纯无水乙醇将姜精油溶解,过滤。柱温:室温;流动相:乙腈-甲醇-水(40:5:55);流速0.8ml/min;进样量:20μl;检测波长280nm。根据标样的保留时间进行定性,用外标法计算姜酚的含量。Wherein, the determination method of gingerol content is as follows: adopt HPLC method; Dissolve ginger essential oil with chromatographically pure absolute ethanol, filter. Column temperature: room temperature; mobile phase: acetonitrile-methanol-water (40:5:55); flow rate: 0.8ml/min; injection volume: 20μl; detection wavelength: 280nm. According to the retention time of the standard sample, the content of gingerol was calculated by the external standard method.

(3)凹凸棒的活化(3) Activation of attapulgite

选择凹凸棒晶体含量大于50%、碳酸盐含量小于10%的凹凸棒粘土矿石类型。取研磨至200目的凹凸棒粉末,加入装有质量百分浓度为20%的盐酸的烧杯中,塑料薄膜密封,在60℃水浴中磁力搅拌10h。然后,10000rpm离心除去上清液,去离子水洗涤沉淀多次,至上清液pH值至中性、颜色透明。再将水洗后的沉淀加入10%(质量百分浓度)氯化钠水溶液中,超声形成悬浮体系;然后,在60℃水浴中磁力搅拌10h;10000rpm离心,取上层浅灰色固体,电热恒温鼓风干燥箱中70℃干燥至恒重,得到活化后的凹凸棒。Select the attapulgite clay ore type with attapulgite crystal content greater than 50% and carbonate content less than 10%. Take the attapulgite powder ground to 200 mesh, put it into a beaker filled with 20% hydrochloric acid by mass, seal it with a plastic film, and stir it magnetically in a water bath at 60°C for 10 hours. Then, the supernatant was removed by centrifugation at 10,000 rpm, and the precipitate was washed with deionized water for several times until the pH of the supernatant was neutral and the color was transparent. Add the precipitate after washing with water to 10% (mass percent concentration) sodium chloride aqueous solution, and ultrasonically form a suspension system; then, stir magnetically in a water bath at 60°C for 10 hours; centrifuge at 10,000rpm, take the upper layer of light gray solid, and blow it with electric heating and constant temperature Dry to constant weight at 70°C in a drying oven to obtain activated attapulgite.

实施例2Example 2

本实施例采用实施例1中制备的芝麻素提取物、姜精油和活化后的凹凸棒进行动物试验,以考察芝麻素提取物、姜精油和活化后的凹凸棒调理肠道功能、保护肠黏膜、抗菌抗炎、促进肠道健康的作用。本实施例中采用的芝麻素是以芝麻素提取物的形式进行添加,根据芝麻素提取物中芝麻素含量为698.07mg/g,计算使用的芝麻素提取物的质量。This example uses the sesamin extract, ginger essential oil and activated attapulgite prepared in Example 1 to carry out animal experiments to investigate how the sesamin extract, ginger essential oil and activated attapulgite regulate intestinal function and protect intestinal mucosa , antibacterial and anti-inflammatory, and promote intestinal health. The sesamin used in this example is added in the form of a sesamin extract, and the mass of the sesamin extract used is calculated according to the sesamin content in the sesamin extract being 698.07 mg/g.

制备大肠杆菌菌悬液:将大肠杆菌接种于LB培养基中,37℃振荡培养12h,将大肠杆菌培养液离心得到菌体沉淀,灭菌生理盐水冲洗菌体沉淀2次,离心后再用灭菌生理盐水制成2×1010CFU/mL的大肠杆菌悬液,4℃保存备用。Preparation of Escherichia coli bacterial suspension: inoculate Escherichia coli in LB medium, shake culture at 37°C for 12 hours, centrifuge the Escherichia coli culture solution to obtain the bacterial cell precipitate, wash the bacterial cell precipitate with sterilized normal saline twice, and then use it after centrifugation Bacterial saline to make 2×10 10 CFU/mL E. coli suspension and store at 4°C for later use.

建立大肠杆菌感染动物腹泻模型:C57BL/6J小鼠实验前12h禁食、自由饮水。每只小鼠腹腔注射大肠杆菌液0.5mL,当小鼠出现明显的腹泻症状、水样便、精神萎靡、行动迟缓等症状时,表明大肠杆菌感染动物腹泻模型建立成功;对照组的每只小鼠,腹腔注射等体积的灭菌生理盐水。To establish an animal diarrhea model infected with Escherichia coli: C 57 BL/6J mice were fasted for 12 hours before the experiment and had free access to water. Each mouse was intraperitoneally injected with Escherichia coli solution 0.5mL, and when the mice had obvious symptoms of diarrhea, watery stool, listlessness, sluggishness and other symptoms, it indicated that the Escherichia coli infection animal diarrhea model was successfully established; Rats were intraperitoneally injected with an equal volume of sterile saline.

试验设计:6周龄SPF级C57BL/6J小鼠108只(雌雄各半)。所有小鼠在恒温恒湿的SFP级动物房中适应3天,控制12h光照/黑暗,环境温度为25%,期间小鼠自由进食和进水。适应结束后,采用随机方法将小鼠分为9组(每组12只,雌雄各半),分别为正常对照组、模型对照组、芝麻素(ZMS,60mg·kg-1·d-1)组、姜精油(GEO,60mg·kg-1·d-1)组、活化后的凹凸棒(PGS,60mg·kg-1·d-1)组、ZMS+GEO(30+30mg·kg-1·d-1)组、ZMS+PGS(30+30mg·kg-1·d-1)组、GEO+PGS(30+30mg·kg-1·d-1)组、ZMS+GEO+PGS(20+20+20mg·kg-1·d-1)组。连续给药6天。Experimental design: 108 6-week-old SPF grade C 57 BL/6J mice (half male and half male). All mice were acclimatized for 3 days in an SFP grade animal room with constant temperature and humidity, controlled 12h light/dark, and the ambient temperature was 25%, during which the mice had free access to food and water. After the adaptation, the mice were randomly divided into 9 groups (12 in each group, half male and half male), respectively normal control group, model control group, sesamin (ZMS, 60mg·kg -1 ·d -1 ) group, ginger essential oil (GEO, 60mg·kg -1 ·d -1 ) group, activated attapulgite (PGS, 60mg·kg -1 ·d -1 ) group, ZMS+GEO (30+30mg·kg -1 ·d -1 ) group, ZMS+PGS (30+30mg·kg -1 ·d -1 ) group, GEO+PGS (30+30mg·kg -1 ·d -1 ) group, ZMS+GEO+PGS (20 +20+20 mg·kg -1 ·d -1 ) group. Continuous administration for 6 days.

检测指标包括:饲料每天称重一次并更换,计算平均小鼠摄食量。每天记录小鼠体重。实验期间观察小鼠精神状态、胃肠道反应、运动和反应能力等情况。腹泻指标:将小鼠放入铺有滤纸的鼠笼内,观察小鼠腹泻情况;计算腹泻率。The detection indicators include: the feed is weighed and replaced once a day, and the average food intake of mice is calculated. Mouse body weights were recorded daily. During the experiment, the mental state, gastrointestinal reaction, movement and reaction ability of the mice were observed. Diarrhea index: Put the mice into a mouse cage covered with filter paper, observe the diarrhea of the mice; calculate the diarrhea rate.

动物实验结果如下表1-3所示。The results of the animal experiments are shown in Tables 1-3 below.

表1对小鼠体重的影响Table 1 Effects on mouse body weight

Figure BDA0004120773130000041
Figure BDA0004120773130000041

注:表1中,若某组给药多种药剂,则对应的剂量一栏内若干数字相加,其中数字的位置与给药一栏内的药剂相对应,例如ZMS+GEO组,剂量一栏内“30+30”表示给药芝麻素30mg.kg.d-1和姜精油30mg.kg.d-1,下同;与正常对照组相比,“*”表示P<0.05,“**”表示P<0.01;与模型对照组相比,“#”表示P<0.05,“##”表示P<0.01。Note: In Table 1, if a certain group is given multiple medicines, the numbers in the corresponding dose column are added together, and the positions of the numbers correspond to the medicines in the administration column. For example, in the ZMS+GEO group, dose one "30+30" in the column means the administration of sesamin 30mg.kg.d -1 and ginger essential oil 30mg.kg.d -1 , the same below; compared with the normal control group, " * " means P<0.05, " * * "means P<0.01; compared with the model control group, "#" means P<0.05, "##" means P<0.01.

表2对小鼠摄食量的影响Table 2 Effects on the food intake of mice

Figure BDA0004120773130000042
Figure BDA0004120773130000042

Figure BDA0004120773130000051
Figure BDA0004120773130000051

注:表2中,与正常对照组相比,“*”表示P<0.05,“**”表示P<0.01;与模型对照组相比,“#”表示P<0.05,“##”表示P<0.01。Note: In Table 2, compared with the normal control group, " * " means P<0.05, " ** " means P<0.01; compared with the model control group, "#" means P<0.05, "##" means P<0.01.

表3对小鼠腹泻率的影响The influence of table 3 on mouse diarrhea rate

Figure BDA0004120773130000052
Figure BDA0004120773130000052

Figure BDA0004120773130000061
Figure BDA0004120773130000061

结果表明,与正常对照组相比,模型对照组小鼠体重、摄食量明显降低,腹泻率明显升高。与模型对照组相比,芝麻素(ZMS)、姜精油(GEO)、凹凸棒(PGS)干预可明显恢复腹泻小鼠的体重和摄食量,降低腹泻率,促进小鼠的康复。说明芝麻素(ZMS)、姜精油(GEO)、凹凸棒(PGS)具有调理肠道功能、抗菌抗炎、保护肠黏膜、促进肠道健康的作用;芝麻素、姜精油和凹凸棒三者组合明显优于单用或两者组合,具有协同增效作用。上述结果说明芝麻素、姜精油和凹凸棒三者组合具有协同增强药效的作用。The results showed that, compared with the normal control group, the body weight and food intake of the mice in the model control group were significantly reduced, and the diarrhea rate was significantly increased. Compared with the model control group, the intervention of sesamin (ZMS), ginger essential oil (GEO), and attapulgite (PGS) can significantly restore the weight and food intake of mice with diarrhea, reduce the rate of diarrhea, and promote the recovery of mice. It shows that sesamin (ZMS), ginger essential oil (GEO), and attapulgite (PGS) have the functions of regulating intestinal function, antibacterial and anti-inflammation, protecting intestinal mucosa, and promoting intestinal health; the combination of sesamin, ginger essential oil and attapulgite It is obviously better than single use or combination of both, and has synergistic effect. The above results show that the combination of sesamin, ginger essential oil and attapulgite has a synergistic effect of enhancing drug efficacy.

本发明经急性毒性试验结果表明,小鼠灌胃给芝麻素(ZMS)+姜精油(GEO)+凹凸棒(PGS)最大给药量(MTD)为22.9g/kg,相当于有效剂量70倍;动物未出现任何不良反应。说明本发明产品安全,几乎无毒副反应。The results of the acute toxicity test of the present invention show that the maximum administration dose (MTD) of sesamin (ZMS)+ginger essential oil (GEO)+attapulgite (PGS) in mice is 22.9g/kg, which is equivalent to 70 times the effective dose. ; Animals did not have any adverse reactions. It shows that the product of the present invention is safe and has almost no toxic and side effects.

实施例3Example 3

本实施例采用实施例1中制备的芝麻素提取物、姜精油和活化后的凹凸棒制备各种剂型促进肠道健康作用的药物。本实施例中采用的芝麻素是以芝麻素提取物的形式进行添加,根据芝麻素提取物中芝麻素含量为698.07mg/g,计算使用的芝麻素提取物的质量。In this example, the sesamin extract, ginger essential oil and activated attapulgite prepared in Example 1 were used to prepare various dosage forms of drugs for promoting intestinal health. The sesamin used in this example is added in the form of a sesamin extract, and the mass of the sesamin extract used is calculated according to the sesamin content in the sesamin extract being 698.07 mg/g.

含芝麻素提取物、姜精油和活化后的凹凸棒的片剂,每片含60mg芝麻素、120mg姜精油和600mg凹凸棒。将芝麻素、姜精油和凹凸棒混合均匀,按照常规方法制备片剂。Tablets containing sesamin extract, ginger essential oil and activated attapulgite, each containing 60mg sesamin, 120mg ginger essential oil and 600mg attapulgite. Mix the sesamin, ginger essential oil and attapulgite evenly, and prepare tablets according to a conventional method.

含芝麻素提取物、姜精油和活化后的凹凸棒的散剂,每袋含120mg芝麻素、60mg姜精油和600mg凹凸棒。将芝麻素、姜精油和凹凸棒混合均匀,按照常规方法制备散剂。Powder containing sesamin extract, ginger essential oil and activated attapulgite, each bag contains 120mg sesamin, 60mg ginger essential oil and 600mg attapulgite. Mix the sesamin, ginger essential oil and attapulgite evenly, and prepare the powder according to the conventional method.

含芝麻素提取物、姜精油和活化后的凹凸棒的胶囊剂,每粒含60mg芝麻素、30mg姜精油和600mg凹凸棒。将芝麻素、姜精油和凹凸棒混合均匀,按照常规方法制备胶囊剂。Capsules containing sesamin extract, ginger essential oil and activated attapulgite, each containing 60mg sesamin, 30mg ginger essential oil and 600mg attapulgite. Mix the sesamin, ginger essential oil and attapulgite evenly, and prepare capsules according to a conventional method.

每日口服剂量,以有效部位组合物计,芝麻素、姜精油和凹凸棒总质量约为700mg,用于调节改善肠道功能,促进肠道健康(如慢性肠道炎症、功能性消化不良、肠道易激惹综合征等所致的肠道功能紊乱),散剂服用方法为每日2次,每次1袋,温开水冲服;片剂服用方法为每日2次,每次1-2片;胶囊剂服用方法为每日2次,每次1-2粒。1个月为一疗程。Daily oral dose, in terms of effective part composition, the total mass of sesamin, ginger essential oil and attapulgite is about 700mg, which is used to regulate and improve intestinal function and promote intestinal health (such as chronic intestinal inflammation, functional dyspepsia, Intestinal dysfunction caused by irritable bowel syndrome, etc.), the method of taking the powder is 2 times a day, 1 bag each time, washed with warm water; the method of taking the tablet is 2 times a day, 1-2 times a day Tablets; Capsules are taken twice a day, 1-2 capsules each time. 1 month is a course of treatment.

Claims (6)

1. The composition with the effect of promoting intestinal health is characterized by comprising sesamin, ginger essential oil and attapulgite, wherein the mass ratio of sesamin to ginger essential oil to attapulgite is 0.1-2:0.1-2: 10-20.
2. The composition of claim 1, wherein the sesamin is extracted from sesame seed meal, wherein the sesamin content is greater than 50%.
3. Composition according to claim 1 or 2, wherein the ginger essential oil is extracted from ginger with a gingerol content of more than 20%.
4. A composition according to claim 3, wherein the attapulgite has a rod crystal content of greater than 50% and a carbonate content of less than 10%.
5. The composition of claim 4, wherein the attapulgite is ground to a powder of 100-320 mesh.
6. The composition of claim 5, wherein sesamin, ginger essential oil and attapulgite are mixed uniformly, and mixed with excipient to make powder, granule, tablet or capsule.
CN202310231897.8A 2023-01-06 2023-03-07 A composition capable of promoting intestinal health Pending CN116369521A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2023100247037 2023-01-06
CN202310024703 2023-01-06

Publications (1)

Publication Number Publication Date
CN116369521A true CN116369521A (en) 2023-07-04

Family

ID=86962523

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310231897.8A Pending CN116369521A (en) 2023-01-06 2023-03-07 A composition capable of promoting intestinal health

Country Status (1)

Country Link
CN (1) CN116369521A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090054443A1 (en) * 2006-03-15 2009-02-26 Suntory Limited Compositions containing riboflavin and sesamin-class compounds
JP2009279011A (en) * 2009-09-02 2009-12-03 Tsujido Chemical Corp Food composition
JP2010024240A (en) * 2009-10-30 2010-02-04 Tsujido Chemical Corp Clathrate and method for producing the same
CN106110276A (en) * 2016-08-24 2016-11-16 南京财经大学 A kind of have the complex improving functional gastrointestinal disorder effect

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090054443A1 (en) * 2006-03-15 2009-02-26 Suntory Limited Compositions containing riboflavin and sesamin-class compounds
JP2009279011A (en) * 2009-09-02 2009-12-03 Tsujido Chemical Corp Food composition
JP2010024240A (en) * 2009-10-30 2010-02-04 Tsujido Chemical Corp Clathrate and method for producing the same
CN106110276A (en) * 2016-08-24 2016-11-16 南京财经大学 A kind of have the complex improving functional gastrointestinal disorder effect

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
刘苗苗 等: ""果蔬与肠道菌群互作及其健康功效研究进展"", 《中国食品学报》, vol. 22, no. 4, 30 April 2022 (2022-04-30), pages 387 - 407 *

Similar Documents

Publication Publication Date Title
Yang et al. Tracking evidences of Coptis chinensis for the treatment of inflammatory bowel disease from pharmacological, pharmacokinetic to clinical studies
CN104906406B (en) A kind of natural drug composition and preparation method for preventing and treating alcoholic liver injury
CA2386215C (en) Method for treatment of chronic venous insufficiencies using an extract of red vine leaves
ES2646927T3 (en) Herbal supplements and methods of use thereof
CN1943745A (en) A Chinese traditional medicinal preparation for treatment of urticaria
CN106110276A (en) A kind of have the complex improving functional gastrointestinal disorder effect
CN105770008A (en) New application of folium syringae extract in preparing drugs for resisting drug-resistant bacterium infection diseases
CN101933973A (en) Medicament composition for preventing and treating liver damage
KR101439405B1 (en) Composition for preventing or treating renal disease
CN108570116A (en) Yellowish green frizzle mushroom polysaccharide and preparation method and the medical application in preventing diabetes
CN104857435A (en) Chinese herbal compound composition with antineoplastic activity as well as preparation method and application thereof
CN101066356A (en) Chinese medicine for treating sterility of epididymitis
CN116369521A (en) A composition capable of promoting intestinal health
CN1943741A (en) A Chinese traditional medicinal preparation for treatment of eczema
RU2408383C1 (en) Composition with antineoplastic and adaptogenic activity (versions) and based drug (versions)
CN1883679A (en) Medicine for treating pulmonary tuberculosis
CN111840448B (en) Preparation method and application of anti-chapping compound traditional Chinese medicine liposome
CN111905017A (en) A kind of Chinese medicine composition and application of anti-Helicobacter pylori
CN1424052A (en) Medicine for treating chronic hepatitis B
KR102052081B1 (en) The composition for preventing and treating hepatitis B
CN102210725B (en) Application of hypericum japonicum thunb general flavone in preparing medicament for treating hepatic fibrosis
CN101028392B (en) Chinese medicine for treating hyperlipemia
CN1733000A (en) Water fern extract and its application in the preparation of antitumor preparations
CN101347607A (en) A soft capsule composed of effective parts of ginger and magnolia bark and its application in medicine
CN111588751A (en) A Chinese medicinal composition for treating acute gastroenteritis and dysentery

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination